St
Stallergenes Greer
Antony FRFounded 19621,200 employees
Private CappharmaPrivateImmunology
Platform: Allergy Immunother
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| STA-4766 | STA-4766 | Phase 1/2 | 2 | CD19 | PSPT2D | ||
| Gelinaritide | STA-4380 | Phase 2 | 1 | CFTR | SMAMM | ||
| Pemiinavolisib | STA-7858 | Phase 1/2 | 2 | WRN | Prostate CaMG | ||
| Nidaglumide | STA-329 | Approved | 3 | C5 | MCCIgAN |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)